Hyperion DeFi (HYPD) Stock: Buy, Sell, or Hold?
HYPD - Hyperion DeFi, Inc. Common Stock
$3.49
-0.10 (-2.79%)
▼
5d:
+5.76%
30d:
+29.74%
90d:
+31.2%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When HYPD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HYPD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HYPD shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.63
Based on -30.7% avg growth
INTRINSIC VALUE TODAY
$1.01
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HYPD is currently trading at $3.49, which is considered extended relative to its 30-day fair value range of $2.69 to $3.33. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.4) compared to its historical average (6.0). Remarkably, the market is currently pricing in an annual earnings decline of 38.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HYPD is in a downtrend. Immediate support is located at $3.03, while resistance sits at $3.88.
Market Sentiment: HYPD scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.82 (+181.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HYPD is in a downtrend. Immediate support is located at $3.03, while resistance sits at $3.88.
Market Sentiment: HYPD scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.82 (+181.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.69 -
$3.33
Company Quality Score
27/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
28.6%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 181.5% below Wall St target ($9.82)
- WARNING: Composite score 27/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.69 -
$3.33
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.03
Resistance Level
$3.88
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.44
Wall Street Target
$9.83
(+181.5%)
Revenue Growth (YoY)
1559.5%
Profit Margin
474.9%
Valuation Discount vs History
-38.0% cheaper
PE vs Historical
1.4 vs 6.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-38.0%
(market-implied from PE analysis)
1-Year Target
$3.14
(-10%)
2-Year Target
$2.83
(-19%)
3-Year Target
$2.54
(-27%)
3-Yr Target (if PE normalizes)
(PE: 1→6)
$10.59
(+203%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: -65.4%)
$35.58
(+920%)
Base:
(SPY PE: 1.4, Growth: -65.4%)
$2.54
(-27%)
Bear:
(PE: 1.2, Growth: -65.4%)
$2.16
(-38%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.4 to 6.0
Stabilization Target:
$14.52
(+316.0%)
PE Expansion Potential:
+316.0%
Share & Embed Analysis
Last updated: September 13, 2026 1:07 PM ET
Data refreshes hourly during market hours. Next update: 2:07 PM
Data refreshes hourly during market hours. Next update: 2:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 52 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 50 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$27 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 50 HOLD |
